| | | Total (n = 13,172) | EES (n = 5,154) | BES (n = 3,007) | ZES (n = 5,011) | value |
| | Demographics | | | | | | | Age (years) | 64.0 ± 10.9 | 64.0 ± 10.8 | 64.0 ± 11.0 | 64.1 ± 11.0 | 0.621 | | Male (n, %) | 9216/13172 (70.0%) | 3537/5154 (68.6%) | 2119/3007 (70.5%) | 3560/5011 (71.0%) | 0.023 | | Body mass index (kg/m2) | 24.6 ± 3.2 | 24.6 ± 3.2 | 24.6 ± 3.3 | 24.6 ± 3.1 | 0.911 | | Coexisting condition | | | | | | | Diabetes mellitus (n, %) | 4828/13172 (35.9%) | 1912/5154 (37.1%) | 1032/3007 (34.3%) | 1784/5011 (35.6%) | 0.036 | | Hypertension (n, %) | 8109/13172 (61.6%) | 3226/5154 (62.6%) | 1766/3007 (58.7%) | 3117/5011 (62.2%) | 0.001 | | Dyslipidemia (n, %) | 7966/13172 (60.5%) | 2705/5154 (52.5%) | 2080/3007 (69.2%) | 3181/5011 (63.5%) | <0.001 | | Peripheral vascular disease (n, %) | 259/13172 (2.0%) | 90/5154 (1.7%) | 58/3007 (1.9%) | 111/5011 (2.2%) | 0.231 | | Chronic renal failure (n, %) | 572/13172 (4.3%) | 217/5154 (4.2%) | 121/3007 (4.0%) | 234/5011 (4.7%) | 0.326 | | Cardiac risk factors | | | | | | | Current smoker (n, %) | 3936/13172 (29.9%) | 1573/5154 (30.5%) | 890/3007 (29.6%) | 1473/5011 (29.4%) | 0.431 | | Previous myocardial infarction (n, %) | 739/13172 (5.6%) | 346/5154 (6.7%) | 146/3007 (4.9%) | 247/5011 (4.9%) | <0.001 | | Previous PCI (n, %) | 1941/13172 (14.7%) | 762/5154 (14.8%) | 401/3007 (13.3%) | 778/5011 (15.5%) | 0.027 | | Previous coronary artery bypass surgery (n, %) | 239/13172 (1.8%) | 95/5154 (1.8%) | 56/3007 (1.9%) | 88/5011 (1.8%) | 0.924 | | Family history of coronary artery disease (n, %) | 789/13172 (6.0%) | 284/5154 (5.5%) | 189/3007 (6.3%) | 316/5011 (6.3%) | 0.177 | | Left ventricular ejection fraction <40% (n, %) | 746/11267 (6.6%) | 318/4604 (6.9%) | 137/2465 (5.6%) | 291/4198 (6.9%) | 0.056 | | Clinical indication of PCI | | | | | | | STEMI (n, %) | 1926/13064 (14.7%) | 717/5122 (14.0%) | 484/2967 (16.3%) | 725/4975 (14.6%) | 0.017 | | NSTEMI (n, %) | 1922/13064 (14.7%) | 728/5122 (14.2%) | 463/2967 (15.6%) | 731/4975 (14.7%) | 0.234 | | Unstable angina (n, %) | 4385/13064 (33.6%) | 1772/5122 (34.6%) | 929/2967 (31.3%) | 1684/4975 (33.8%) | 0.009 | | Stable angina (n, %) | 4317/13064 (33.0%) | 1650/5122 (32.2%) | 1006/2967 (33.9%) | 1661/4975 (33.4%) | 0.240 | | Silent ischemia (n, %) | 514/13064 (3.9%) | 255/5122 (5.0%) | 85/2967 (2.9%) | 174/4975 (3.5%) | <0.001 | | Lesion characteristics | | | | | | | Left main disease (n, %) | 820/13172 (6.2%) | 329/5154 (6.4%) | 170/3007 (5.7%) | 321/5011 (6.4%) | 0.335 | | Multiple target lesions (n, %) | 3872/13172 (29.4%) | 1542/5154 (29.9%) | 831/3007 (27.6%) | 1499/5011 (29.9%) | 0.055 | | At least on target lesion with | | | | | | | Type B2/C lesion (n, %) | 10301/13172 (78.2%) | 3905/5154 (75.8%) | 2395/30007 (79.6%) | 4001/5011 (79.8%) | <0.001 | | Bifurcation (n, %) | 5339/13172 (40.5%) | 1918/5154 (37.2%) | 1284/3007 (42.7%) | 2137/5011 (42.6%) | <0.001 | | Severe calcification (n, %) | 1151/13172 (8.7%) | 437/5154 (8.5%) | 311/3007 (10.3%) | 403/5011 (8.0%) | 0.001 | | Tortuosity (>45°) (n, %) | 2821/13172 (21.4%) | 1140/5154 (22.1%) | 600/3007 (20.0%) | 1081/5011 (21.6%) | 0.067 | | Thrombotic total (n, %) | 1438/13172 (10.9%) | 505/5154 (9.8%) | 375/3007 (12.5%) | 558/5011 (11.1%) | 0.001 | | ISR as a target lesion (n, %) | 505/13151 (3.8%) | 225/5139 (4.4%) | 105/3007 (3.5%) | 175/5005 (3.5%) | 0.037 | | Long lesion (≥28 mm) (n, %) | 3925/13172 (29.8%) | 1756/5154 (34.1%) | 547/3007 (18.2%) | 1622/5011 (32.4%) | <0.001 | | Small diameter (≤2.75 mm) (n, %) | 6066/13172 (46.1%) | 2473/5154 (48.0%) | 1236/3007 (41.1%) | 2357/5011 (47.0 %) | <0.001 | | IVUS-guided (n, %) | 4946/13172 (37.5%) | 2033/5154 (39.4%) | 1022/3007 (34.0%) | 1891/5011 (37.7%) | <0.001 | | Previous treated lesion (n, %) | 984/13172 (7.5%) | 404/5154 (7.8%) | 151/3007 (5.0%) | 429/5011 (8.6%) | <0.001 | | Side branch treatment (n, %) | 1176/13172 (8.9%) | 408/5154 (7.9%) | 320/3007 (10.6%) | 448/5011 (8.9%) | <0.001 | | Number of stents | 1.6 ± 0.9 | 1.7 ± 0.9 | 1.6 ± 0.9 | 1.6 ± 0.9 | <0.001 | | Stent average diameter (mm) | 3.1 ± 0.5 | 3.1 ± 0.4 | 3.1 ± 0.4 | 3.0 ± 0.5 | 0.001 | | Total stent length (mm) | 38.8 ± 25.7 | 39.8 ± 26.1 | 34.8 ± 23.4 | 40.3 ± 26.4 | <0.001 | | Device success (n, %) | 12949/13170 (98.3%) | 5074/5152 (98.5%) | 2947/3007 (98.0%) | 4928/5011 (98.3%) | 0.261 | | Lesion success (n, %) | 12927/13170 (98.2%) | 5069/5152 (98.4%) | 2944/3007 (97.9%) | 4914/5011 (98.1%) | 0.244 | | Procedural success (n, %) | 12914/13170 (98.1%) | 5061/5152 (98.2%) | 2941/3007 (97.8%) | 4912/5011 (98.0%) | 0.392 | | Angiography f/u (n, %) | 5340/13172 (40.5%) | 1954/5152 (37.9%) | 1401/3007 (46.6%) | 1985/5011 (39.6%) | <0.001 | | Dedicated angiography f/u (n, %) | 2866/13172 (21.8%) | 1085/5152 (21.1%) | 943/3007 (31.4%) | 838/5011 (16.7%) | <0.001 | | DAPT duration (days) | 689 ± 373 | 711 ± 375 | 674 ± 374 | 675 ± 371 | <0.001 |
|
|
